Lv1
10 积分 2025-07-02 加入
An International Consensus on Appropriate Management of Corticosteroids in Clinical Trials in Inflammatory Bowel Disease
1年前
已关闭
Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS)
1年前
已完结
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
1年前
已完结
Differences in the Adverse Event Burden of Corticosteroid Use in Inflammatory Bowel Disease as Reported Between Adverse Event Reporting Systems and a Patient Questionnaire
1年前
已完结
Hepatic safety and efficacy of immunomodulatory drugs used in patients with autoimmune hepatitis
1年前
已关闭
Toxic nephropathy: Adverse renal effects caused by drugs
1年前
已完结
Immunosuppression with cyclosporine versus tacrolimus shows distinctive nephrotoxicity profiles within renal compartments
1年前
已完结
Nephrotoxicity from Vancomycin Combined with Piperacillin-Tazobactam: A Comprehensive Review
1年前
已关闭
Infection toxicity assessment of tumor necrosis factor α inhibitors in the treatment of IBD: a real-world study based on the US food and drug administration adverse events reporting system (FAERS)
1年前
已完结
Nephrotoxicity of the BRAF Inhibitors Vemurafenib and Dabrafenib
1年前
已完结